Design Therapeutics, Inc.
DSGN
$14.83
$0.443.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 207.40M | 222.82M | 219.85M | 205.97M | 216.28M |
| Total Receivables | 1.79M | 1.82M | 1.68M | 1.38M | 1.35M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.83M | 2.40M | 2.26M | 1.68M | 2.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 212.01M | 227.05M | 223.78M | 209.03M | 219.79M |
|
|
|||||
| Total Current Assets | 212.01M | 227.05M | 223.78M | 209.03M | 219.79M |
| Net Property, Plant & Equipment | 3.12M | 3.39M | 2.42M | 2.74M | 3.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 215.13M | 230.44M | 226.20M | 211.77M | 222.89M |
|
|
|||||
| Total Accounts Payable | 3.14M | 2.28M | 2.31M | 1.91M | 1.01M |
| Total Accrued Expenses | 7.47M | 7.38M | 9.85M | 8.39M | 6.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 631.00K | 536.00K | 890.00K | 866.00K | 844.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.24M | 10.19M | 13.06M | 11.17M | 8.75M |
|
|
|||||
| Total Current Liabilities | 11.24M | 10.19M | 13.06M | 11.17M | 8.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.03M | 2.20M | 645.00K | 877.00K | 1.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.27M | 12.39M | 13.70M | 12.05M | 9.85M |
|
|
|||||
| Common Stock & APIC | 537.44M | 532.96M | 509.11M | 480.37M | 476.74M |
| Retained Earnings | -334.81M | -314.64M | -297.01M | -281.01M | -264.01M |
| Treasury Stock & Other | -771.00K | -268.00K | 403.00K | 358.00K | 305.00K |
| Total Common Equity | 201.86M | 218.05M | 212.50M | 199.72M | 213.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 201.86M | 218.05M | 212.50M | 199.72M | 213.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 201.86M | 218.05M | 212.50M | 199.72M | 213.04M |
|
|
|||||